News

 It isn't only going to be offered to claimants but overweight people in work as well.

From the article:

"Up to 3,000 obese patients – a mixture of those in and out of work, and on sickness leave – will be recruited for a five-year study that will explore whether the medication boosts productivity and could bring more people back to the workplace."

I wonder if there will be disclosure of "side effects" when using this "medication" and how many casualties we'll see.

The genetics of obesity:

"Although changes in the environment have undoubtedly driven the rapid increase in prevalence, obesity results from an interaction between environmental and innate biological factors. Crucially, there is a strong genetic component underlying the large interindividual variation in body weight that determines people’s response to this ‘obesogenic’ environment. Twin, family and adoption studies have estimated the heritability of obesity to be between 40% and 70%. As a consequence, genetic approaches can be leveraged to characterize the underlying physiological and molecular mechanisms that control body weight.

Classically, we have considered obesity in two broad categories: so-called monogenic obesity, which is inherited in a Mendelian pattern, is typically rare, early-onset and severe and involves either small or large chromosomal deletions or single-gene defects; and polygenic obesity (also known as common obesity), which is the result of hundreds of polymorphisms that each have a small effect. Polygenic obesity follows a pattern of heritability that is similar to other complex traits and diseases. Although often considered to be two distinct forms, gene discovery studies of monogenic and polygenic obesity have converged on what seems to be broadly similar underlying biology. Specifically, the central nervous system (CNS) and neuronal pathways that control the hedonic aspects of food intake have emerged as the major drivers of body weight for both monogenic and polygenic obesity. Furthermore, early evidence shows that the expression of mutations causing monogenic obesity may — at least in part — be influenced by the individual’s polygenic susceptibility to obesity."

Source: https://www.nature.com/articles/s41576-021-00414-z

Many people reflexively use derogatory language when looking at a person who is overweight, I find my own mind being hyper-critical, yet I also must consider there are determining factors at play through gene expression.

It is a complex situation to address and I don't see "jabs" being a solution whatsoever, especially considering the potential dire side effects of using this "medication".

The poor souls engaging in the study should receive ongoing remuneration.

Remember, Mel Stride said early in this year that food delivery was best suited for over 50s!

They don't care about people getting jobs or what type of jobs they would like to do. All they're after is taking as many claimants as possible off benefits.

I'm sorry to hear about your friend's death, but a heart attack is a known postoperative complication of bariatric surgery. It's something he would have been told of prior to surgery, and he would have had to sign a consent form to say he understood the risks.

That was not a conspiracy to kill off fat unemployed people. Qualifying for bariatric surgery on the NHS is not easy.

The Mounjaro injections is a 5 year pilot based in Manchester, covering obese people in and out of work. No-one is being forced to take the injections, it's entirely voluntary.

The drug has already been through extensive testing prior to its release. Of course as for every drug it has side effects, some of which are considerable.

Personally, I wouldn't take it.

You just need to read more about it for the truth.